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Longer lifespan, altered metabolism, and stress resistance in
Drosophila from ablation of cells making insulin-like ligands
Abstract
The insulin/insulin-like growth factor-like signaling pathway, present in all multicellular organisms,
regulates diverse functions including growth, development, fecundity, metabolic homeostasis, and
lifespan. In flies, ligands of the insulin/insulin-like growth factor-like signaling pathway, the Drosophila
insulin-like peptides, regulate growth and hemolymph carbohydrate homeostasis during development
and are expressed in a stage- and tissue-specific manner. Here, we show that ablation of Drosophila
insulin-like peptide-producing median neurosecretory cells in the brain leads to increased fasting
glucose levels in the hemolymph of adults similar to that found in diabetic mammals. They also exhibit
increased storage of lipid and carbohydrate, reduced fecundity, and reduced tolerance of heat and cold.
However, the ablated flies show an extension of median and maximal lifespan and increased resistance
to oxidative stress and starvation.
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The insulininsulin-like growth factor-like signaling pathway,
present in all multicellular organisms, regulates diverse functions
including growth, development, fecundity, metabolic homeosta-
sis, and lifespan. In flies, ligands of the insulininsulin-like growth
factor-like signaling pathway, the Drosophila insulin-like peptides,
regulate growth and hemolymph carbohydrate homeostasis dur-
ing development and are expressed in a stage- and tissue-specific
manner. Here, we show that ablation of Drosophila insulin-like
peptide-producing median neurosecretory cells in the brain leads
to increased fasting glucose levels in the hemolymph of adults
similar to that found in diabetic mammals. They also exhibit
increased storage of lipid and carbohydrate, reduced fecundity,
and reduced tolerance of heat and cold. However, the ablated flies
show an extension of median and maximal lifespan and increased
resistance to oxidative stress and starvation.
aging
The insulininsulin-like growth factor (IGF)-like signaling(IIS) pathway is present throughout multicellular animals
(1). Its functions include regulation of growth (2–5), develop-
ment (6), and metabolic homeostasis (7). Also, the pathway has
been shown to regulate adult lifespan, resistance to stress (8–10),
and fecundity in Caenorhabditis elegans, Drosophila, and mice
(11–14).
In mice, both deletion of the insulin receptor in white-adipose
tissue and ubiquitous heterozygosity for a null mutation in the
IGF-I receptor increase longevity, implying that both insulin and
IGF-I signaling may regulate lifespan (10, 15). In C. elegans and
Drosophila, mutation of the single IIS receptor (6, 16, 17), the
single insulin receptor substrate (9, 18), or the PI3 kinase
(19–22), the protein kinases Akt (23) and Sgk-1 (24), or over-
expression of the forkhead transcription factor (25–27), all
increase lifespan and delay or reduce fecundity. Thus, the role of
reduced insulin signaling in lifespan-extension appears to be
conserved. In light of the different roles of insulin signaling in
diverse tissues within an organism, the array of phenotypes that
result from altered systemic signaling may be separable.
In the genomes of the invertebrates C. elegans and Drosophila,
single genes encode the intracellular components of the signaling
pathway, with the exception of the triplication of the protein
kinase B, Akt, SGK-1 in C. elegans (23). In contrast, there are
multiple invertebrate-genes for the insulin-like ligands, with
seven in theDrosophila genome (3) and 38 inC. elegans (28). The
genes encoding the seven Drosophila insulin-like peptides
(DILPs) were originally identified by a similarity search that used
the four conserved cysteine residues within the insulin A chain
as bait (3). DILP1–DILP7 are predicted to resemble preproin-
sulin at the structural level, and therefore, they are considered
orthologous to mammalian insulin, rather than IGF. The relative
simplicity of the intracellular signaling-pathway, together with
the genetic diversification of DILPs, implies that the multiple
functions of IIS may be mediated in part by functional diversi-
fication of the ligands. In support of this notion, the genes
encoding the DILPs are independently transcriptionally regu-
lated in response to nutrition, as well as in a tissue- and
stage-specific manner during development (3, 5). However, the
distinct biochemical roles that the different ligands play in these
contexts remain to be identified.
The mechanisms by which IIS regulates lifespan and fecundity
and the nature of any causal relationships between these phe-
notypes and the other traits regulated by this pathway are not
understood. We have investigated the roles of the insulin-like
ligands in adult Drosophila. We have determined that, in adults,
three of the dilp genes are expressed in brain neurosecretory
cells, two of them exclusively so. We have investigated the
consequences of ablation of these cells for adult lifespan, fecun-
dity, stress resistance, and metabolic phenotypes.
Methods
Fly Stocks and Maintenance. The control whiteDahomey stock was
derived by backcrossing w1118 into the outbred wild-type Da-
homey background. Upstream activating sequence (UAS)-reaper
(rpr) and dilp2-GAL (5) were backcrossed into wDah five times.
UAS-GFP (1521) and UAS-LacZ (1776) were obtained from
Bloomington Stock Center. Stocks were maintained and exper-
iments were conducted at 25°C on a 12:12-h lightdark cycle at
constant humidity by using standard sugaryeast medium (29).
In Situ Hybridization. RNA in situ hybridizations on whole-mount
adult central nervous systems, ovaries, and other abdominal
organs by using digoxigenin (DIG)- and FITC-labeled dilp
probes were performed as described in ref. 5.
Immunohistochemistry. DILP2 expression was determined by us-
ing rabbit anti-DILP2 diluted 1:500 according to the procedure
described in ref. 30 and a secondary Texas red-conjugated
donkey anti-rabbit IgG (Jackson ImmunoLabs).
Confocal Microscopy. Confocal imaging of UAS-GFP expression
and Fast Red fluorescence was carried out on an LSM 510
microscope (Zeiss). The fluorophore Fast Red was excited at
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488 nm and fluorescence measured beyond 545 nm. Confocal
image stacks were converted to projections by using LSM 510
software (Zeiss). Cell counts were performed on 3D reconstruc-
tions of expression in the mNSCs of Drosophila brains by using
AXIOVERT software (Zeiss).
Quantitative RT-PCR. Total RNA was extracted by using TRIzol
(GIBCO) according to the manufacturer’s instructions. mRNA
in total RNA was reverse transcribed by using oligo(dT) primer
and the Superscript II system (Invitrogen). Quantitative PCR
was performed by using the PRISM 7000 sequence-detection
system (Applied Biosystems), SYBR Green (Molecular Probes),
ROX ReferenceDye (Invitrogen), and Hot StarTaq (Qiagen,
Valencia, CA) by following the manufacturers’ instructions. For
detailed information, see Supporting Materials and Methods,
which is published as supporting information on the PNAS web
site.
Lifespan. Procedures for lifespan studies were as described in refs.
9 and 31. For detailed information, see Supporting Materials and
Methods.
Fecundity. The number of eggs laid per vial of females was
counted, and the number of females per vial and the number of
days (3 or 4) over which they had laid were noted. Data are
reported as the mean number of eggs laid per day per female 
SEM over each 3- or 4-day period.
Stress Tests. UAS-rpr; dilp2-GAL and UAS-rpr mated
females were generated as for lifespan. Survival was measured
on (i) 20 mM paraquat in standard food (oxidative stress) or (ii)
1% agar (starvation). Time to knock-down was measured for
flies exposed to 38.5°C (heat) and time to recovery from
cold-shock was measured for flies exposed to 0°C for 4 h (32).
Two experiments were performed for each treatment. For heat
and paraquat, 6- and 10-day-old flies were tested in each
experiment.
Trehalose and Glucose Measurement.Hemolymph was pooled from
8–10 females after a 5-h starvation on 1% agar. Flies were
decapitated, and hemolymph was collected from the thorax by
capillary action. Glucose amount was determined in 0.3 l of
pooled liquid by using Infinity Glucose Reagent (ThermoElec-
tron). Whole-f ly trehalose was measured as described in ref. 33,
by using the glucose assay outlined above. For detailed infor-
mation, see Supporting Materials and Methods.
Lipid and Glycogen Measurements. The glycogen and lipid content
of individual, adult female flies were measured 3 days after
eclosion (n  20) according to the method described in ref. 34,
which was modified to exclude protein separation. Data are
expressed relative to the fresh body weight of each fly.
Statistical Analyses. All statistical analyses were performed by
using JMP (version 4.0.5) software (SAS Institute, Cary, NC).
Lifespan data were subjected to survival analysis (log-rank tests)
and presented as survival curves. Mortality (x) was estimated
as xln (px), where px is the probability of an individual alive
at age x  1 surviving to age x days (35). Maximum-likelihood
methods, executed in WINMODEST (36), were used to estimate
mortality parameters of the Gompertz model: x  aebx. Fecun-
dity, cold recovery, glucose, trehalose, lipid, and glycogen data
were tested for normality by using the Shapiro–Wilk W test on
studentized residuals (37). One-way ANOVA was used, and
means comparisons were made by using Student’s t test. Data are
presented as means SEM, and an asterisk indicates significant
difference from control (P  0.05).
Results
Characterization of dilp2, dilp3, and dilp5 Expression in Adult Flies.
Previous work has characterized the expression and distribution
of the DILPs inDrosophila larvae (3, 5). However, little is known
about these molecules in adult f lies. To detect the presence and
location of RNA transcripts of dilp2, dilp3, and dilp5 in adults,
RNA in situ hybridizations were performed, which revealed
expression of all three genes in a cluster of cells in the adult brain
that correspond to the median neurosecretary-cells (mNSC) of
the pars intercerebralis (38) (Fig. 1A). Expression of the other
four dilps was not detectable in these cells by in situ hybridization
using probes complementary to dilp1, dilp4, dilp6, and dilp7 (data
not shown). dilp5 expression was also detected in the ovary as
noted in ref. 5, whereas dilp2 and dilp3 could not be detected
anywhere else in the adult body (data not shown). These
observations were supported by quantitative RT-PCR that re-
vealed relatively strong expression of dilp2, dilp3, and dilp5 in
head extracts but not dilp2 transcript, barely detectable levels of
dilp3, and low levels of dilp5 in extracts from bodies (Fig. 1B).
To determine whether the three dilp genes were all expressed
in the same cells, double in situ hybridizations were performed.
Combining the probes for dilp5 with dilp2 and dilp5 with dilp3
showed that all three genes were coexpressed in the same set of
cells (Fig. 1 C and D). The number of these dilp-expressing
mNSCs per individual was determined by fluorescent in situ
hybridization using probes for each of the three genes separately
(Fig. 1E).Within each brain, the number of cells expressing these
dilps was bilaterally symmetrical, and it varied from five to seven
pairs.
Targeted Disruption of dilp Expression by Cell Ablation. All studies
on the role of IIS in adult f lies have manipulated the pathway
components in target tissues.We sought to investigate the effects
Fig. 1. Characterization of expression of dilp2, dilp3, and dilp5 in adult
femaleDrosophila. Gene expression of dilp2, dilp3, and dilp5was determined
in 5-day-old adult female brains by RNA in situ hybridization and quantitative
RT-PCR of the control genotype (UAS-rpr). (A) Exemplar in situ hybridiza-
tion using a dilp2 DIG-labeled RNA probe and alkaline phosphatase-
conjugated anti-DIG Ab. Cells containing the target gene constitute the
median neurosecretory cells (mNSCs) in the pars intercerebralis of the adult
brain. (Scale bars, 80m.) (B) Separate RNA extracts from heads and bodies of
adult female flies were assayed for the presence of dilp2, dilp3, and dilp5
transcripts by RT-PCR. Data are shown as mean copy number  SEM. Double
in situ hybridizations were performed by using a FITC-labeled dilp5 probe and
DIG-labeleddilp2and3probes, followed by alkaline phosphatase-conjugated
anti-DIG and anti-FITC Abs. (C) Double staining for dilp2 (visualized with fast
red) anddilp5probes (visualized with BCIPNBT) revealed their colocalization.
n  7. (D) Likewise, double staining using DIG-labeled dilp3 (fast red) and
FITC-labeled dilp5 (BCIPNBT) probes revealed their colocalization (n 8). (E)
Fluorescent in situ hybridization was used to quantify dilp-expressing mNSCs.
This example shows a fluorescent dilp3 probe localized to six pairs of mNSCs.
(Scale bar, 10 m.) Seven brains were examined by using the dilp2 probe, 12
brains were examined by using the dilp3 probe, and 11 brains were examined
by using the dilp5 probe.
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of lowered IIS activity as a result of disruption of the insulin
ligands. To achieve this aim, transcription of the proapoptotic
gene rpr was driven by a GAL4 transgene whose expression was
determined by a fragment of the dilp 2 promoter (dilp2GAL4).
This construct has been shown to express exclusively in the
mNSCs of larval brains, starting during late third-instar (5). Fig.
2 shows expression in adult brains of UAS-GFP driven by this
dilp2GAL4 construct in the absence (A) and presence (B) of
UAS-rpr. dilp2-driven rpr expression clearly resulted in a com-
plete ablation of the cells in the adult brain in which it was
expressed, as shown by the absence of any fluorescence in the
ablated flies.
However, in situ hybridizations using brains from ablated flies
revealed some expression of each of the dilp genes in a variable
number of residual mNSCs (Fig. 2 C–E). This expression was
confirmed by RT-PCR data that showed that expression of each
of the dilps was reduced to 30–40% of the levels in wild-type
brains (Fig. 2F). Because only a fragment of the dilp2 promoter
was used to drive rpr expression, the expression pattern of the
transgene may not always have fully replicated that found for the
full-length promoter. This supposition was supported by immu-
nostaining brains from control (Fig. 2G) and ablated (Fig. 2 H
and I) animals by using a DILP2 Ab. Although in some brains
there was no detectable protein (Fig. 2H), DILP-producing cells
were still detectable in others (Fig. 2I). Attempts to quantify
DILP2 levels in whole-body protein extracts by Western blot
analysis failed because of the low abundance of the ligand (data
not shown).
IIS activity is required for larval growth, and reduced activity
in components of the signaling pathway have been shown to
result in flies that are dramatically smaller and have delayed
development (3, 39, 40). In contrast, the mNSC-ablated flies
reported here were only slightly smaller than controls, and they
showed no developmental delay, presumably because of the late
developmental onset of expression of theGAL4 driver transgene
used in these experiments (5).
mNSC-Ablated Flies Have Longer Lifespan and Reduced Fecundity.
Reduced IIS activity has a conserved role in extending adult
lifespan. To investigate the effects of mNSC ablation and the
resulting reduced levels of dilp2, dilp3, and dilp5 on lifespan, we
assayed the longevity of female (mated and virgin) and male
flies. The ablated flies exhibited a significant increase in median
and maximum lifespan over that of control f lies (Fig. 3 A–C).
Median lifespan was increased by 10.5% in males and 18.5% and
33.5% in virgin and mated females, respectively. These increases
in lifespan were accompanied by decreases in age-specific egg
laying for virgin and mated females (Fig. 3 D and E).
Age-specific mortality analysis of lifespan data from mated
female flies was performed (Fig. 3F). Over the linear portion of
the mortality increase, fitting of a Gompertz model revealed a
significant difference in the initial rate of mortality but no
change in the slope of the mortality trajectory (Table 1). Thus,
detectable aging-related mortality started later in the ablated
flies but then proceeded at the same rate as in controls.
Physiological Changes in mNSC-Ablated Flies: Altered Carbohydrate
and Lipid Metabolism. Insulin signaling is known to be involved in
the regulation of energy homeostasis in mammals. One mani-
festation of this is that mammals with reduced systemic insulin
signaling (such as that in diabetes) exhibit fasting hyperglycemia
because of inappropriate regulation of glucose uptake from
circulation and release from energy stores in the liver. To test
whether reduction of insulin signaling has similar effects in
Drosophila, we measured the levels of several molecules that are
resources for energy generation.
Insects contain two types of sugar in circulation: glucose and
trehalose. Glucose is obtained from the diet, and trehalose is
used as a homeostatic molecule that originates from the fat body
and is used to distribute sugar to peripheral tissues (41). He-
molymph was extracted from female flies that had been starved
for 5 h, and the levels of these two sugars was measured. Glucose
was elevated 2-fold above control values in mNSC-ablated flies
(Fig. 4A), whereas trehalose was slightly (15%) but significantly
lowered in ablated flies versus controls (Fig. 4B).
Examination of stored energy pools by using whole-body
extracts revealed that mNSC-ablated flies contained signifi-
cantly higher levels of trehalose (64% higher), glycogen (44%
higher), and lipids (10% higher) relative to body mass when
compared with controls (Fig. 4 C–E). Under normal conditions,
these three storage molecules represent the largest readily
accessible energy resource available to the fly. Thus, mNSC-
ablated flies exhibit generally higher levels of stored energy and
an altered profile of circulating carbohydrates compared with
controls.
Altered Resistance to Stress. Enhanced resistance to various
stresses is often associated with interventions that extend lifes-
pan. We found that mNSC-ablated flies survived longer than
controls when fed paraquat in their food. Assuming equal rates
of paraquat ingestion, this indicates enhanced resistance to
oxidative stress (Fig. 5A). Furthermore, the ablated flies were
moderately starvation resistant when compared with controls
(Fig. 5B). In contrast, the ablated flies showed greater sensitivity
to heat shock (Fig. 5C) and took more time to recover from cold
shock (Fig. 5D).
Discussion
Several genetic interventions that have been shown to extend
lifespan in worms (6, 16, 21), fruit f lies (9, 17, 26, 27), and mice
(10, 15) reduce the activity of the insulin-like signaling pathway.
Here, we report extension ofDrosophila lifespan by ablating cells
in the adult brain that produce three of the seven DILPs.
During the preadult period, these peptides activate the IIS
pathway in tissues expressing the insulin receptor to promote
Fig. 2. The mNSC-specific expression of the dilp2-GAL driver in the adult
brain and the effect of mNSC ablation on dilp expression. (A and B) Confocal
image (z-stack projection) of dilp2-GAL-driven expression of UAS-GFP in con-
trol (UAS-GFP;dilp2GAL) (A) and ablated (UAS-rpr;UAS-GFP
;dilp2GAL) (B) adult female brains. (C–E) RNA in situ hybridizations were
performed by using DIG-labeled probes and an alkaline phosphatase-
conjugated anti-DIG Ab to UAS-rpr; dilp2GAL adult female brains. (C)
dilp2. (D) dilp3. (E) dilp5. (F) The effect of mNSC ablation on dilp expression
measured by RT-PCR. Data are mean fold differences in expression between
the ablated genotype (UAS-rpr; dilp2GAL) and the control (UAS-rpr)
 SEM. (G–I) Adult mNSCs immunostained with an Ab against DILP2 in a
control brain (UAS-rpr; n  5) (G), and ablated brains (UAS-rpr; dilp2-
GAL) (H and I). For sample sizes and residual mNSC numbers, see Table 2,
which is published as supporting information on the PNAS web site.







growth (4, 5, 42). During adulthood, f lies and worms with
reduced IIS activity exhibit higher lipid levels, increased oxida-
tive stress resistance, and longer lifespan (6, 9, 16, 17, 21, 26, 27,
43). Each of these phenotypes is shared by the mNSC-ablated
flies reported here, supporting the idea that the cell ablation is
acting by reducing one or more of DILP2, DILP3, and DILP5,
leading to lowered systemic insulin signaling. These data are
supported by lowered levels of the dilp transcripts in the ablated
flies. Although it remains possible that other unknown effects of
the cell ablation are responsible for the observed lifespan
extension, data from C. elegans further support IIS involvement,
because RNA interference to specifically reduce ins-7 (1 of 38
genes encoding IIS ligands) has been shown to increase adult
lifespan (44). These data support a model in which specific
insulin-like ligands are involved in shortening adult lifespan,
because their reduction is sufficient for lifespan extension de-
spite the persistence of the remaining ligands.
Reduced insulin signaling in mammals is associated with the
disease-state diabetes, characterized by high blood glucose,
because of its decreased uptake from circulation into tissues such
as muscle and liver, as well as increased glucose release into the
blood from catabolism of glycogen and protein by the liver (45).
Like diabetic mammals, mNSC-ablated flies showed higher
starving levels of circulating glucose, indicating that one or more
of DILP2, DILP3, and DILP5 may be required to stimulate
Fig. 3. mNSC-ablated flies are long-lived and females show reduced fecundity. (A) Survival of UAS-rpr; dilp2-GAL virgin females (red), and dilp2-GAL
(brown), UAS-rpr (blue), and w (green) controls. Median lifespans are as follows: UAS-rpr; dilp2-GAL, 64 days (18.5% increase over UAS-rpr control,
P0.0001;n173);dilp2GAL, 47 days (n187); UAS-rpr, 54 days (n232); andw, 47 days (n202). (B) Survival of UAS-rpr;dilp2-GALmated females
(red), and dilp2-GAL (brown), UAS-rpr (blue), and w (green) controls. Median lifespans are as follows: UAS-rpr; dilp2-GAL, 56 days (33.5% increase
over UAS-rpr control, P  0.0001; n  93); dilp2-GAL, 32 days (n  115); UAS-rpr, 42 days (n  88); and w, 35 days (n  112). (C) Survival of UAS-rpr;
dilp2-GALmales (red), anddilp2-GAL (brown), UAS-rpr (blue), andw (green) controls. Median lifespans are as follows: UAS-rpr;dilp2-GAL, 41 days
(10.5% increase over dilp2-GAL control, P 0.0001; n 140); dilp2-GAL, 37 days (n 150); UAS-rpr, 35 days (n 128); and w, 34 days (n 195). (D and
E) Fecundity of females from experiment shown in A (D) and B (E). Data are given as mean number of eggs laid per female per day SEM. *, P 0.05, compared
with controls. (F) Age-specific mortality analysis of UAS-rpr (n 1,186) and dilp2-GAL4UAS-rpr (n 1,143) mated females. Natural log of the mortality rate
(x) is plotted.
Table 1. Estimates of the parameters of the Gompertz mortality
model with 95% lower and upper confidence intervals
Genotype a* LCI UCI b† LCI UCI
dilp2GALrpr 0.00015 0.00010 0.00023 0.21128 0.19835 0.22505
UAS-rpr 0.00037 0.00028 0.00049 0.22061 0.21012 0.23162
Mortality models and maximum-likelihood analysis were executed by using
WINMODEST (36). LCI, lower confidence interval; UCI, upper confidence interval.
*Initial mortality rate.
†Rate of exponential increase in mortality with age early in life.
Fig. 4. The effect of mNSC ablation on hemolymph glucose and trehalose
levels, and whole-body trehalose, glycogen, and lipid content. (A) Hemo-
lymph glucose concentration in UAS-rpr and UAS-rpr;dilp2-GALflies.
(B) Hemolymph trehalose concentration in UAS-rpr and UAS-rpr; dilp2-
GAL flies (n  8). (C) Whole-fly trehalose content in UAS-rpr and UAS-
rpr; dilp2-GAL flies per mg of fly (fresh weight) (n  10). (D) Glycogen
content of UAS-rpr and UAS-rpr; dilp2-GAL flies per mg of fly (fresh
weight) (n 21). (E) Lipid content of UAS-rpr and UAS-rpr; dilp2-GAL
flies per mg of fly (fresh weight) (n  17). Data are shown as means  SEM.
*, P  0.05, compared with control.
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glucose uptake in adult f lies in a manner similar to mammalian
insulin. Such a homeostatic control of blood sugar has been
demonstrated in Drosophila, in which the early larval ablation of
the DILP-producing mNSCs results in increased hemolymph
sugar levels during development (4).
In flies and mammals, certain components of the insulin
signaling pathway are represented by several genes. In Drosoph-
ila, the insulin-like ligands are encoded by seven genes, whereas
in mammals the intracellular signaling components are multiply
encoded. For some of these genes, it is also known that paral-
ogues have different spatiotemporal expression patterns, indi-
cating that they have functionally distinct roles (46). In general,
functional diversity among IIS pathway paralogues raises the
intriguing possibility that the lifespan-extension phenotype as-
sociated with lowered IIS activity may be separable from the
various accompanying metabolic defects.
In stark contrast to reduction of systemic insulin-signaling in
mammals, which results in diabetes, whose associated patholo-
gies shorten lifespan, targeted ablation of the insulin receptor in
white adipose-tissue in the mouse results in lifespan extension
(15). Interestingly, reduced IIS activity in fat body (analogous to
the mammalian adipose-tissue and liver) alone is also sufficient
to elicit lifespan extension in flies (26, 27) and worms (47).
However, in contrast to mammals, reduction of insulin ligands as
a result of the cell ablation reported here or by RNAi for ins-7
in C. elegans (44) resulted in animals that were longer lived than
controls. Although the exact relevance of the invertebrate
models to the mammalian disease state is uncertain, a possible
explanation is that the mortality caused by diabetes in mammals
may be due to physiological damage that neither Drosophila nor
C. elegans are at risk of contracting, such as the microvascular
and macrovascular damage that results from hyperglycemia (45).
A feature that has been shared by all long-lived IIS mutant
flies, including the mNSC-ablated flies described here, is in-
creased lipid content (17, 39). Although also true of long-lived
IIS-mutant worms (6), this elevation of lipid content may not be
essential for the longevity phenotype (48). In mammals, reduced
activity of the insulin pathway can also be associated with
dyslipidemia. Neuron-specific disruption of the insulin-receptor
gene in mice (NIRKO mice) resulted in decreased fertility and
diet-dependent increased adiposity (49). In Drosophila, fat stor-
age is mainly in the fat body. Thus, the role of IIS in generation
and storage of fat in this tissue may be evolutionarily conserved.
In addition, mNSC-ablated flies possessed increased relative
levels of storage carbohydrates that could also be expected of
NIRKO mice. The increased fat, trehalose, and glycogen stores
seen in the mNSC-ablated flies are also unlikely to be causal in
the extension of lifespan, because long-lived chico (Drosophila
IRS) flies show no increase in glycogen content (39). Interest-
ingly, studies of long-lived insulin-receptor mutant mice indicate
that decreased fat levels are associated with longevity (15).
IIS is required for normal growth in Drosophila (50), and
lifespan extension by this pathway has been associated with
reduced body size and delayed development time, reminiscent of
the constellation of phenotypes seen in long-lived dwarf mice
(51). However, the reduction in body size caused by reduction of
IIS signaling in development is not necessary for extension of
lifespan. chico heterozygotes are wild type in body size and yet
show extended lifespan (9), as do flies with adult-specific over-
expression of the IIS transcription factor dFOXO (26, 27).
Increased resistance to various forms of physiological stress is
often correlated with life-extending genetic alterations and has
been proposed to be causal (52). The increased thermotolerance
and accumulation of heat-shock proteins observed in IIS-mutant
worms is consistent with this hypothesis (53, 54). However, we
have found that long-lived mNSC-ablated flies are more sensi-
tive to hot and cold treatments than controls, indicating that
enhanced resistance to thermal stresses is not necessary for
lifespan extension. One possible cause for the ablated flies
reduced thermotolerance is their lowered circulating trehalose
concentrations. Trehalose has been proposed to play a protective
role against anoxia in Drosophila by preventing protein aggre-
gation (55) and is a requirement for the stress-resistance of
stationary-phase yeast cells (56, 57). However, this attractive
hypothesis remains questionable because the ablated flies only
contain lowered trehalose in circulation, while possessing higher
levels of whole-body trehalose. Thus, any role for this disaccha-
ride in thermal tolerance would be limited to its levels in the
hemolymph. Another aspect of stress resistance that apparently
correlates with longevity in mNSC-ablated flies and other long-
lived mutant IIS flies is enhanced resistance to oxidative stress
(9, 26, 27). However, note that in each case the prooxidant
paraquat was administered by feeding. Therefore, it is possible
that unquantified feeding-rate differences between genotypes
alter the dose received by each treatment group. Notwithstand-
ing this possibility, increased oxidative stress resistance has been
found for long-lived IIS-mutant worms (43) and mice (10), and
in each case, it is associated with increased activity of the
antioxidant enzyme superoxide dismutase (SOD). Also, in-
creased activity of the JNK signaling pathway in Drosophila
results in both increased resistance to paraquat and extended
lifespan (58). Although some conflicting results exist in the
literature regarding the sufficiency of overexpression of these
systems to extend the lifespan ofDrosophila (59–62), recent data
support the hypothesis that SOD activity is indeed limiting for
lifespan (63). Therefore, these studies agree that enhanced
oxidative stress resistance correlates with and may be both
necessary and sufficient for retarded aging.
Reduced female fecundity is also often correlated with life-
span extension in IIS-mutant animals (for review, see ref. 64).
Fig. 5. Long-lived mNSC-ablated adults are resistant to oxidative stress and
starvation but show reduced thermotolerance. (A) Survival of 10-day-old adult
female flies on 20 mM paraquat added to standard food. Sample sizes were
n  100 for each genotype in the first experiment and n  85 for each
genotype in second. (B) Survival of females during starvation (1% agar). n 
144 fordilp2GALUAS-rpr;n 150 for UAS-rpr in experiment 1;n 182 for
dilp2GALUAS-rpr; and n  154 for UAS-rpr in experiment 2. For both
experiments, the median lifespans were as follows: dilp2GALUAS-rpr, 12
days; and UAS-rpr, 10 days. (C) Survival of 6-day-old females with 38.5°C
heat. n  20 for each genotypeexperiment. (A–C) Data are shown as mean
survival for each time point over two experiments SEM. P 0.05, compared
with control. (D) Mean time to recover from cold treatment of 9-day-old
females  SEM (n  50 for each genotype).







The mNSC-ablated flies presented are not sterile but have
reduced fertility that could possibly contribute to the long
lifespan of these flies. In worms and flies, reduced fertility has
been uncoupled from longevity caused by reduced IIS activity (9,
16). Furthermore, control of fertility can be effected by only a
subset of insulin signaling functions in mammals because knock-
outs of different IRS proteins in mice yield different effects on
fertility (65, 66). In worms, reduced IIS activity limited to larval
stages was shown to reduce fecundity without increasing lifespan,
whereas lowering IIS during the adult period only extended
lifespan without lowering fecundity (67). It is possible that a
similar effect is also at work in Drosophila because our mNSC
ablation occurred during the final larval stage (5), resulting in
lowered IIS activity during the late larval and pupal periods as
well as during adulthood. However, in Drosophila, IIS acts at
least in part in the adult to determine fecundity, because lifespan
extension by overexpression of dFOXO that was confined to the
fat body of adult f lies led to reduced fecundity (26). It would be
interesting to characterize the relationship between this inter-
vention and mNSC-ablation, because their phenotypes are con-
sistent with a role for the DILPs signaling to the fat body to elicit
alterations in lifespan and fecundity.
Together, the data presented here demonstrate that lowered
levels of a subset of the ligands that are responsible for systemic
insulin signaling in flies results in lifespan extension. Therefore,
only a subset of the roles of IIS needs to be lowered to effect
longevity. This extension of lifespan occurred despite a doubling
of blood glucose levels, an interesting phenomenon when viewed
in light of the pathological effects of diabetes in mammals.
Further characterization of the mechanisms by which this inter-
vention works is well suited to the omic techniques because at
least some of the observable physiological correlates of longevity
apparently do not indicate causation.
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